Delivery Order SPE2DB20D2104-SPE2DB24FQ83H
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.52 firm fixed-price delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of July 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $3,526.04 firm fixed-price contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,741.68 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
- This federal contract award, with a ceiling value of $4,530.26, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used for the treatment of diabetes. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $3,004.24 firm-fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract has an ultimate completion date of June 22, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, solicited by the Defense Logistics Agency (DLA), was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,738.42 firm fixed-price delivery order covers the procurement of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,467.12 for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a broad...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $6,176.99. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) worth $1,694.66. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to treat type 2 diabetes. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,186.29 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of December 8, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ83HDelivery Order
This federal contract award is a delivery order valued at $5,639.12 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military and veteran healthcare programs globally. This delivery order is issued under that IDC, which enables the efficient procurement of essential medications and medical commodities by the DLA. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/19/23 |